Sanofi India Appoints Siraj Azmat Chaudhry as Additional Director
Mumbai – March 25, 2026 – Sanofi India Ltd. announced the appointment of Siraj Azmat Chaudhry as an Additional Director and Independent Director at a board meeting held on Wednesday, March 25, 2026. The appointment is effective April 1, 2026, and Chaudhry will serve for an initial term of five years, until March 31, 2031, subject to member approval at the company’s 70th Annual General Meeting.The board also approved the convening of the 70th Annual General Meeting on April 29, 2026, at 3:30 p.m. IST via video conferencing. The company had previously recommended a final dividend of Rs. 48 per equity share of Rs. 10 each for the financial year ended December 31, 2025, pending member approval. The register of members and share transfer books will be closed from April 23, 2026, to April 29, 2026.
Siraj A. Chaudhry holds an MBA from the Indian Institute of Foreign Trade (IIFT) and a B. Com (Hons) from Shri Ram College of Commerce. He brings over 35 years of experience, including 20 years in leadership roles within the agriculture and food sectors. He previously served as Chairman of Cargill India and holds several other independent director positions including Jubilant Ingrevia Ltd., Carrier Air Conditioning and Refrigeration India, Bikaji Foods International and Triveni Engineering and Industries Ltd.
According to company disclosures, Mr. Chaudhry is not related to any existing directors and has not been debarred by regulatory authorities.
| Particulars | Details | |
|---|---|---|
| 1 | Reason for change | Appointment of Mr. Siraj Azmat Chaudhry (DIN: 00161853) as an Additional Director and Independent Director. |
| 2 | Date of appointment & term | Appointed effective April 1, 2026, for a five-year term. |
| 5 | Disclosure of non-debarment | Mr. Chaudhry confirms he is not debarred by SEBI or the Ministry of Corporate Affairs. |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.